← SynDRA
PRN-1371
SynDRA canonical compound SYN0039239 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | FGFR1 | FGFR2 | FGFR3 | FGFR4 |
|---|
| Mechanism of action | protein tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FGFR1 INHIBITOR
- FGFR2 INHIBITOR
- FGFR3 INHIBITOR
- FGFR4 INHIBITOR
- tyrosine kinase inhibitor
Cross-references
Synonyms
- PRN1371
- PUIXMSRTTHLNKI-UHFFFAOYSA-N
- UNII-S3OPE9IA3Q
- S3OPE9IA3Q
- 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
- GTPL9788
- US9567334, Example 6
- SCHEMBL16993012
- BDBM286984
- BCP20493
- s8578
- AKOS032954157
- CS-7485
- compound 34 [PMID: 28665128]
- HY-101768
- J3.662.238E
- 6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one
- RefChem:176037
- pan FGFR Inhibitor PRN1371
- FGFR 1-4 Inhibitor PRN1371
- Pan-FGFR Tyrosine Kinase Inhibitor PRN1371
- C26H30Cl2N6O4
- orb1296270
- SCHEMBL29360330
- PRN 1371 [WHO-DD]
- GLXC-15386
- EX-A2927
- PRN1371?
- NSC801089
- CCG-270053
- NSC-801089
- AC-35543
- BP179867
- MS-30190
- C92492
Look up PRN-1371 in the interactive SynDRA portal →